טוען...
Subclinical Hypothyroidism in TAFRO Syndrome
OBJECTIVE: TAFRO syndrome is rare, and its underlying mechanisms currently remain unknown. Furthermore, standard therapeutic strategies have yet to be established. One of the hallmarks of TAFRO is pathological hypercytokinemia, which involves vascular endothelial growth factor (VEGF). A correlation...
שמור ב:
| הוצא לאור ב: | Intern Med |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Japanese Society of Internal Medicine
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794168/ https://ncbi.nlm.nih.gov/pubmed/31178506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2717-19 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|